No black box warning on record for Edarbyclor
As of the latest FDA labeling reviewed, Edarbyclor (AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Edarbyclor medicine page for the complete safety profile.